Likelihood Ratios in Assessing the Safety of New Medicines

Wall R.J. & Shani M. (2008). Are animal models as good as we think? Theriogenology 69, 2–9.

Hartung T. (2013). Food for Thought… Look back in anger – What clinical studies tell us about preclinical work. ALTEX 30, 275–291.

Pippin J.J. & Sullivan K. (undated). Dangerous medicine: Examples of animal-based “safety” tests gone wrong. Washington, DC, USA: The Physicians Committee for Responsible Medicine. Available at: http://www.pcrm.org/research/animaltestalt/animaltesting/dangerous-medicine-examples-of-animal-based-tests (Accessed 03.11.14).

Ashton R. , De Wever B. , Fuchs H.W. , Gaça M. , Hill E. , Krul C. , Poth A. & Roggen E.L. (2014). State of the art on alternative methods to animal testing from an industrial point of view: Ready for regulation? ALTEX 31, 357–363.

Pound P. , Ebrahim S. , Sandercock P. , Bracken M.B. & Roberts I. (2004). Where is the evidence that animal research benefits humans? British Medical Journal 328, 514–517.

Kaste M. (2005). Use of animal models has not contributed to development of acute stroke therapies: Pro. Stroke 36, 2323–2324.

Pippin J.J. (2005). The Need for Revision of PreMarket Testing: The Failure of Animal Tests of COX-2 Inhibitors, 23pp. Washington, DC, USA: The Physicians Committee for Responsible Medicine. Available at: pcrm.org/pdfs/research/testing/exp/COX2Report.pdf (Accessed 04.11.14).

Hackam D.G. & Redelmeier D.A. (2006). Translation of research evidence from animals to humans. Journal of the American Medical Association 296, 1731–1732.

Knight A. (2008). Systematic reviews of animal experiments demonstrate poor contributions towards human healthcare. Reviews on Recent Clinical Trials 3, 89–96.

Matthews R.A.J. (2008). Medical progress depends on animal models – doesn't it? Journal of the Royal Society of Medicine 101, 95–98.

Seok J. , Warren H.S. , Cuenca A.G. , Mindrinos M.N. , Baker H.V. , Xu W. , Richards D.R. , McDonald-Smith G.P. , Gao H. , Hennessy L. , Finnerty C.C. , López C.M. , Honari S. , Moore E.E. , Minei J.P. , Cuschieri J. , Bankey P.E. , Johnson J.L. , Sperry J. , Nathens A.B. , Billiar T.R. , West M.A. , Jeschke M.G. , Klein M.B. , Gamelli R.L. , Gibran N.S. , Brownstein B.H. , Miller-Graziano C. , Calvano S.E. , Mason P.H. , Cobb J.P. , Rahme L.G. , Lowry S.F. , Maier R.V. , Moldawer L.L. , Herndon D.N. , Davis R.W. , Xiao W. , Tompkins R.G. & Inflammation and Host Response to Injury, Large Scale Collaborative Research Program (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences of the USA 110, 3507–3512.

Li A.P. (2004). Accurate prediction of human drug toxicity: A major challenge in drug development. Chemico-biological Interactions 150, 3–7.

Arnardottir A.H. , Haaijer-Ruskamp F.M. , Straus S.M. , Eichler H.G. , de Graeff P.A. & Mol P.G. (2011). Additional safety risk to exceptionally approved drugs in Europe? British Journal of Clinical Pharmacology 72, 490–499.

van Meer P.J. , Kooijman M. , Gispen-de Wied C.C. , Moors E.H. & Schellekens H. (2012). The ability of animal studies to detect serious post marketing adverse events is limited. Regulatory Toxicology & Pharmacology 64, 345–349.

Berry S. (2012). Safety Intelligence Program Provides Insight into Drug-Induced Cardiac Effects. Stone, UK: Instem plc. Available at: http://www.biowisdom.com/content/safety-intelligence-program (Accessed 04.11.14).

Fourches D. , Barnes J.C. , Day N.C. , Bradley P. , Reed J.Z. & Tropsha A. (2010). Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical Research in Toxicology 23, 171–183.

Bailey J. , Thew M. & Balls M. (2013). An analysis of the use of dogs in predicting human toxicology and drug safety. ATLA 41, 335–350.

Bailey J. , Thew M. & Balls M. (2014). An analysis of the use of animal models in predicting human toxicology and drug safety. ATLA 42, 181–199.

Altman D.G. & Bland J.M. (1994). Diagnostic tests 2: Predictive values. British Medical Journal 309, 102.

Brooker P. (2014). The use of second species in toxicology testing. ATLA 42, 147–149.

Bailey J. (2014). A response to the ABPI's Letter to the Editor on the use of dogs in predicting drug toxicity in humans. ATLA 42, 149–153.